Table 1.
Country | HEV immunoglobulin G (IgG) seroprevalence | HEV RNA positive | References |
---|---|---|---|
Highly endemic countries | |||
The Netherlands | 27.0% | 1:2671 | Slot et al. 2013 |
1:600 | Zaaijer 2015 | ||
France | 22.4% | Mansuy et al. 2016 | |
1:2218 | Gallian et al. 2014 | ||
1:744 | Gallian et al. 2017 | ||
Germany | 29.5% | 1:1200 | Vollmer et al. 2012 |
China | 32.6% | 1:1493 | Guo et al. 2010 |
Low/intermediate endemic countries | |||
England | 12.2% | 1:2848 | Hewitt et al. 2014 |
16% | 1:7000 | Ijaz et al. 2012 | |
12% | Beale 2011 | ||
Scotland | 4.7% | 1:14520 | Cleland et al. 2013 |
Ireland | 5.3% | 1:5000 | O’Riordan et al. 2016 |
Denmark | 1:2330 | Harritshoj 2016 | |
Sweden | 1:7986 | Baylis et al. 2012 | |
Austria | 13.5% | 1:8416 | Fischer et al. 2015 |
Spain | 19.9% | 1:3333 | Sauleda et al. 2015 |
United States | 16% | - | Xu et al. 2013 |
1:9500 | Stramer et al. 2016 | ||
Australia | 6% | - | Shrestha et al. 2014 |
1:14799 1:74131 |
Shrestha et al. 2016a; Hoad et al. 2017 | ||
New Zealand | 4% | Dalton et al. 2007 | |
Fiji | 2% | Halliday et al. 2014 | |
Japan | 1:8173 | Minagi et al. 2016 | |
1:15075 |